Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Ferrara

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Angewandte Chemie (International Ed. in English)|December 22, 2017
Enantioselective Synthesis of the Cyclopiazonic Acid Family Using Sulfur YlidesOleksandr Zhurakovskyi, Yunus E Türkmen, Lorenz E Löffler, et al.
Journal of Medicinal Chemistry|July 24, 2009
Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2-P4 macrocyclesSteven Harper, Marco Ferrara, Benedetta Crescenzi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNSLeda Ivanova Bencheva, Marilenia De Matteo, Luca Ferrante, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 22, 2023
Current practice for upper gastrointestinal endoscopy: a multicentre study in Lazio, ItalyAngelo Zullo, Stefano Brighi, Mariana Forlino, et al.
Journal of Medicinal Chemistry|January 26, 2008
Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitorsEster Muraglia, Olaf Kinzel, Cristina Gardelli, et al.
Journal of Medicinal Chemistry|September 4, 2008
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infectionVincenzo Summa, Alessia Petrocchi, Fabio Bonelli, et al.
Journal of Medicinal Chemistry|December 15, 2010
Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymeraseFrank Narjes, Benedetta Crescenzi, Marco Ferrara, et al.
Journal of Medicinal Chemistry|September 11, 2007
Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidonesCristina Gardelli, Emanuela Nizi, Ester Muraglia, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Chemmedchem|March 12, 2015
P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325Michael T Rudd, John W Butcher, Kevin T Nguyen, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Angewandte Chemie (International Ed. in English)|December 22, 2017
Enantioselective Synthesis of the Cyclopiazonic Acid Family Using Sulfur YlidesOleksandr Zhurakovskyi, Yunus E Türkmen, Lorenz E Löffler, et al.
Journal of Medicinal Chemistry|July 24, 2009
Inhibitors of the hepatitis C virus NS3 protease with basic amine functionality at the P3-amino acid N-terminus: discovery and optimization of a new series of P2-P4 macrocyclesSteven Harper, Marco Ferrara, Benedetta Crescenzi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNSLeda Ivanova Bencheva, Marilenia De Matteo, Luca Ferrante, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 22, 2023
Current practice for upper gastrointestinal endoscopy: a multicentre study in Lazio, ItalyAngelo Zullo, Stefano Brighi, Mariana Forlino, et al.
Journal of Medicinal Chemistry|January 26, 2008
Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitorsEster Muraglia, Olaf Kinzel, Cristina Gardelli, et al.
Journal of Medicinal Chemistry|September 4, 2008
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infectionVincenzo Summa, Alessia Petrocchi, Fabio Bonelli, et al.
Journal of Medicinal Chemistry|December 15, 2010
Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymeraseFrank Narjes, Benedetta Crescenzi, Marco Ferrara, et al.
Journal of Medicinal Chemistry|September 11, 2007
Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidonesCristina Gardelli, Emanuela Nizi, Ester Muraglia, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variantsVincenzo Summa, Steven W Ludmerer, John A McCauley, et al.
Chemmedchem|March 12, 2015
P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325Michael T Rudd, John W Butcher, Kevin T Nguyen, et al.
Pageof 4